194 filings
6-K
CMMB
Chemomab Therapeutics Ltd
8 May 24
Chemomab Therapeutics Granted 180-Day Extension by Nasdaq to Regain Compliance
7:05am
6-K
CMMB
Chemomab Therapeutics Ltd
3 May 24
Current report (foreign)
4:03pm
20-F
2023 FY
CMMB
Chemomab Therapeutics Ltd
Annual report (foreign)
28 Mar 24
6:03am
6-K
CMMB
Chemomab Therapeutics Ltd
7 Mar 24
Chemomab Therapeutics Announces Year End and Fourth Quarter 2023 Financial Results
7:00am
6-K
CMMB
Chemomab Therapeutics Ltd
3 Jan 24
Chemomab Announces Completion of Patient Enrollment in CM-101 Phase 2 Primary
7:00am
6-K
ar5u 6sgljo
9 Nov 23
Current report (foreign)
8:00am
EFFECT
71t7sw6jg5
6 Nov 23
Notice of effectiveness
12:15am
CORRESP
q6vim1by5
1 Nov 23
Correspondence with SEC
12:00am
F-3/A
qfvsk5
30 Oct 23
Shelf registration (foreign) (amended)
8:33am
F-3
jlbo5nyb2l1
16 Oct 23
Shelf registration (foreign)
4:25pm
6-K
uh65x7x5
14 Aug 23
Current report (foreign)
8:05am
6-K
7newlovtn7j36
8 Aug 23
Current report (foreign)
6:00am
6-K
sgidojwp478 4d9yr8
3 Jul 23
Current report (foreign)
3:49pm
8-K
r0kc5
16 Jun 23
Departure of Directors or Certain Officers
4:01pm
8-K
x3fwyv8 19c
5 Jun 23
Chemomab Therapeutics Announces Executive Leadership Changes and Provides a Corporate Update
7:00am
RW
p900tl303v
2 Jun 23
Registration withdrawal request
4:02pm
8-K
llm3o94fazr
11 May 23
Chemomab Therapeutics Announces First Quarter 2023 Financial Results and Provides a Corporate Update
6:10am